Breakthrough discovery on tau protein opens new paths for Alzheimer’s drug development

A complementary drug to combat Alzheimer’s disease could target a specific part of the nerve cell protein tau.

Top 20 biopharmas’ market cap rises 2% in Q3 2024 amid flurry of drug approvals

The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor optimism improved following the interest rate cuts

November 6, 2024

Child Mind Institute leads effort to enhance fMRI

The Child Mind Institute has released a paper detailing their pioneering study in the journal Nature Human Behaviour titled, “Moving Beyond Processing and Analysis-Related Variation

August 6, 2024

Researchers explore immunomodulating targets for improving glioblastoma therapies

Researchers have delved into the intricate heterogeneity of glioblastoma, a notoriously aggressive brain tumor, using advanced single-cell RNA sequencing and innovative zebrafish avatars. Their findings

October 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.